Store blister packs of SEGLUROMET in the original package.

Keep SEGLUROMET and all medicines out of the reach of children. 

General information about the safe and effective use of SEGLUROMET. 

 Medicines are sometimes prescribed for purposes other than those listed in a Medication Guide. Do not use SEGLUROMET for a condition for which it was not prescribed. Do not give SEGLUROMET to other people, even if they have the same symptoms that you have. It may harm them. You can ask your pharmacist or doctor for information about SEGLUROMET that is written for health professionals.

 For more information about SEGLUROMET, go to www.segluromet.com or call 1-800-622-4477. 

What are the ingredients in SEGLUROMET? 

Active ingredients: ertugliflozin and metformin hydrochloride.

Inactive ingredients: povidone, microcrystalline cellulose, crospovidone, sodium lauryl sulfate, and magnesium stearate.

 The tablet film coating contains the following inactive ingredients: hydroxypropyl methylcellulose, hydroxypropyl cellulose, titanium dioxide, iron oxide red, and carnauba wax.  

Manufactured for: Merck Sharp & Dohme Corp., a subsidiary of

MERCK & CO., INC., Whitehouse Station, NJ 08889, USA

 For patent information, go to: www.merck.com/product/patent/home.html. Copyright © 2017 Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. All rights reserved. 

 usmg-mk8835b-t-1712r000 

 

PRINCIPAL DISPLAY PANEL - 2.5 mg / 500 mg Tablet Bottle Label 

 

NDC 0006-5369-03

 

Segluromet™ 

 

(ertugliflozin and

metformin HCl) tablets 

 

2.5 mg / 500 mg 

 

Dispense the accompanying Medication Guide

to each patient. 

 

Each tablet contains 3.24 mg ertugliflozin L-pyroglutamic

acid (equivalent to 2.5 mg ertugliflozin) and

500 mg of metformin hydrochloride.

 

Rx only 

 

60 Tablets 

 

PRINCIPAL DISPLAY PANEL - 2.5 mg / 500 mg Tablet Bottle Label 

 

PRINCIPAL DISPLAY PANEL - 2.5 mg / 1,000 mg Tablet Bottle Label 

 

NDC 0006-5373-03

 

Segluromet™

(ertugliflozin and

metformin HCl) tablets 

 

2.5 mg / 1,000 mg 

 

Dispense the accompanying Medication Guide

to each patient. 

 

Each tablet contains 3.24 mg ertugliflozin

L-pyroglutamic acid (equivalent

to 2.5 mg ertugliflozin) and

1,000 mg of metformin

hydrochloride.

 

60 Tablets

Rx only 

 

PRINCIPAL DISPLAY PANEL - 2.5 mg / 1,000 mg Tablet Bottle Label 

 

PRINCIPAL DISPLAY PANEL - 7.5 mg / 500 mg Tablet Bottle Label 

 

NDC 0006-5370-03

 

Segluromet™ 

 

(ertugliflozin and

metformin HCl) tablets 

 

7.5 mg / 500 mg 

 

Dispense the accompanying Medication Guide

to each patient. 

 

Each tablet contains 9.71 mg ertugliflozin L-pyroglutamic

acid (equivalent to 7.5 mg ertugliflozin)

and 500 mg of metformin